This is the authors' abstract. We don't add key points for this paper.
Dear Editor, We read with great interest the article by Minawala et al. concerning the relationship between sarcopenia and postoperative complications among older adults with inflammatory bowel disease (IBD).1 Sarcopenia is closely associated with prognosis and disease-related morbidity in IBD.2,3 Therefore, accurately defining sarcopenia and evaluating patients accordingly has become increasingly important. Although the concept of sarcopenia is frequently used in current literature, confusion regarding its definition continues to persist.4 The study measured the Skeletal Muscle Index (SMI) and Total Psoas Index (TPI) using preoperative computed tomography (CT) scans and they measured sarcopenia by SMI and TPI obtained from preoperative CT scans. The authors showed that sarcopenia is linked to a higher risk of postoperative complications in older adults with IBD. Although interconnected, sarcopenia and low muscle mass represent distinct clinical entities. Over the years, there have been various perspectives on the definition of sarcopenia, the modern definition of sarcopenia is described as loss of muscle mass, poor muscle function, and low physical performance by the European Working Group on Sarcopenia in Older People (EWGSOP).5 While muscle mass loss can occur at any age, the loss of muscle mass associated with aging should be considered separately, and this muscle loss should not be assessed independently of the loss of muscle function and muscle mass alone is inadequate for the comprehensive diagnosis of sarcopenia. While sarcopenia has long been considered solely in terms of muscle mass, the current approach is shifting toward the understanding that the fundamental determinant is muscle function.6
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Piyade et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: